Filana Therapeutics, Inc. Grants Receivable
Filana Therapeutics, Inc. (FLNA) had Grants Receivable of $6.70 million as of 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Notes
us-gaap:GrantsReceivable · last filed 2019-03-29
- 2018-12-31: Grants Receivable $6.70M.
- 2018-09-30: Grants Receivable $6.70M.
| Period end | Grants Receivable |
|---|---|
| 2018-12-31 | $6.70M 10-K · filed 2019-03-29 |
| 2018-09-30 | $6.70M 10-Q · filed 2018-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |